ArticlePloS one2025

Identification of silibinin and isotretinoin as potent up-regulators of sFRP4 (Wnt antagonist): In silico prediction and in vitro validation in breast cancer.

Rehana Ramzan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.